FDA recommends that updated Covid shots target omicron subvariant XBB.1.5 this fall

The FDA's decision is a win for vaccine makers Pfizer, Moderna and Novavax, which have all been developing versions of their Covid shots to target XBB.1.5.

from U.S. News https://www.cnbc.com/2023/06/16/fda-covid-shots-should-target-omicron-subvariant-xbbpoint1point5-this-fall.html